XTL Biopharmaceuticals changes record date for annual meeting

Published 18/06/2025, 22:58
XTL Biopharmaceuticals changes record date for annual meeting

XTL Biopharmaceuticals Ltd., a micro-cap biotechnology company with a market capitalization of $12.58 million, has amended the record date for its upcoming Annual and Extraordinary General Meeting of Shareholders. According to an SEC filing submitted today, the company has changed the record date from June 19, 2025, to June 18, 2025, as June 19 is a Federal Holiday.

The meeting will be held on July 21, 2025, at 4:00 p.m. Israel time at the offices of the company’s attorneys, Doron Tikotzky Kantor Gutman & Amit Gross, located at 7 Metsada St., B.S.R Tower 4, 33 Floor, Bnei Brak, Israel.

The company has furnished an amended notice and proxy statement describing the proposals to be voted upon at the meeting, along with a form of proxy card that allows shareholders to vote without attending in person.

XTL Biopharmaceuticals, which trades under the ticker 001-36000, is headquartered at 26 Ben-Gurion St., Ramat Gan, Israel. The company files annual reports under Form 20-F.

The amendment was signed by CEO Noam Band and submitted to the Securities and Exchange Commission as a Form 6-K/A for the month of June 2025.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.